PRICING SHEET TEMPLATE - Attachment 1.xlsx

XLSX spreadsheet 26 KB Posted

Attached to
Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies
Solicitation number
15DDHQ24R00000025
Issued by

About this file

This document is a Pricing Sheet Template for Attachment 1 related to a federal contract opportunity. The contract is for the Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants, and Hallucinogenic Substances Using In Vivo Pharmacological Studies, issued by the Drug Enforcement Administration (DEA). The template provides detailed pricing for various assays and tests to be conducted over five ordering periods, including Locomotor Activity Assay, Antagonist Studies, Drug Discrimination, and Drug Costs. The total estimated price per ordering period is $85,000, with 15 test drugs and 2 reference drugs to be evaluated each period. The related federal contract opportunity provides additional details on the scope of work, which includes investigating the abuse potential of synthetic opioids, depressants, and hallucinogenic substances using in vivo pharmacological studies. Contractors will be required to provide DEA with investigational study results and methodology descriptions.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Summary

PERIODTotal Cost Per Ordering Period
ORDERING PERIOD 1
ORDERING PERIOD 2
ORDERING PERIOD 3
ORDERING PERIOD 4
ORDERING PERIOD 5
Total Cost

ORDERING PERIOD 1

PRICING SHEET TEMPLATE: ATTACHMENT 1
Title:Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies
Agency:Drug Enforcement Administration
ORDERING PERIOD 1
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
1Locomotor Activity Assay Cost17
LOT
2Locomotor Activity Assay Incidental Cost17
LOT
3Antagonist Studies Assay Cost17
LOT
4Antagonist Incidental Cost17
LOT
5Drug Discrimination for initial training17
LOT
6Drug Discrimination for initial training Incidental Cost17
LOT
7Drug Discrimination (monthly maintenance of training drug) Assay Cost17
LOT
8Drug Discrimination (monthly maintenance of training drug) Incidental Cost17
LOT
9Drug Discrimination of test drug Assay Cost17LOT
10Drug Discrimination of test drug Incidental Cost17LOT
11Drug Cost Not to Exceed17LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS
1 TOTAL

ORDERING PERIOD 2

PRICING SHEET TEMPLATE: ATTACHMENT 1
Title:Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies
Agency:Drug Enforcement Administration
ORDERING PERIOD 2
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
1001Locomotor Activity Assay Cost17
LOT
1002Locomotor Activity Assay Incidental Cost17
LOT
1003Antagonist Studies Assay Cost17
LOT
1004Antagonist Incidental Cost17
LOT
1005Drug Discrimination for initial training17
LOT
1006Drug Discrimination for initial training Incidental Cost17
LOT
1007Drug Discrimination (monthly maintenance of training drug) Assay Cost17
LOT
1008Drug Discrimination (monthly maintenance of training drug) Incidental Cost17
LOT
1009Drug Discrimination of test drug Assay Cost17LOT
1010Drug Discrimination of test drug Incidental Cost17LOT
1011Drug Cost Not to Exceed17LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS

ORDERING PERIOD 3

PRICING SHEET TEMPLATE: ATTACHMENT 1
Title:Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies
Agency:Drug Enforcement Administration
ORDERING PERIOD 3
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
2001Locomotor Activity Assay Cost17
LOT
2002Locomotor Activity Assay Incidental Cost17
LOT
2003Antagonist Studies Assay Cost17
LOT
2004Antagonist Incidental Cost17
LOT
2005Drug Discrimination for initial training17
LOT
2006Drug Discrimination for initial training Incidental Cost17
LOT
2007Drug Discrimination (monthly maintenance of training drug) Assay Cost17
LOT
2008Drug Discrimination (monthly maintenance of training drug) Incidental Cost17
LOT
2009Drug Discrimination of test drug Assay Cost17LOT
2010Drug Discrimination of test drug Incidental Cost17LOT
2011Drug Cost Not to Exceed17LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS

ORDERING PERIOD 4

PRICING SHEET TEMPLATE: ATTACHMENT 1
Title:Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies
Agency:Drug Enforcement Administration
ORDERING PERIOD 4
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
3001Locomotor Activity Assay Cost17
LOT
3002Locomotor Activity Assay Incidental Cost17
LOT
3003Antagonist Studies Assay Cost17
LOT
3004Antagonist Incidental Cost17
LOT
3005Drug Discrimination for initial training17
LOT
3006Drug Discrimination for initial training Incidental Cost17
LOT
3007Drug Discrimination (monthly maintenance of training drug) Assay Cost17
LOT
3008Drug Discrimination (monthly maintenance of training drug) Incidental Cost17
LOT
3009Drug Discrimination of test drug Assay Cost17LOT
3010Drug Discrimination of test drug Incidental Cost17LOT
3011Drug Cost Not to Exceed17LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS

ORDERING PERIOD 5

PRICING SHEET TEMPLATE: ATTACHMENT 1
Title:Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies
Agency:Drug Enforcement Administration
ORDERING PERIOD 5
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
4001Locomotor Activity Assay Cost17
LOT
4002Locomotor Activity Assay Incidental Cost17
LOT
4003Antagonist Studies Assay Cost17
LOT
4004Antagonist Incidental Cost17
LOT
4005Drug Discrimination for initial training17
LOT
4006Drug Discrimination for initial training Incidental Cost17
LOT
4007Drug Discrimination (monthly maintenance of training drug) Assay Cost17
LOT
4008Drug Discrimination (monthly maintenance of training drug) Incidental Cost17
LOT
4009Drug Discrimination of test drug Assay Cost17LOT
4010Drug Discrimination of test drug Incidental Cost17LOT
4011Drug Cost Not to Exceed17LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS

File details come from the government source that posted it. Updated .